Sudeep Pharma share price
NSE: SUDEEPPHRMBSE: 544619Chemicals & PetrochemicalsSmall Cap
Sudeep Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2025 · Issue price ₹593
Last close ₹1,022.40up ₹39.40 (4.01%)BSE ₹1,021.90
Share price at the NSE close on 27 Oct 2026. Previous close ₹983.00.
27 Oct: open ₹990.00, high ₹1,027.00, low ₹973.90
Range of traded prices from listing on 28 Nov 2025 to 27 Oct 2026
₹524.05Low, 21 Jan 2026₹1,378.00High, 7 Sep 2026
- Next results date: the board meets on 28 Oct 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹11,548 Cr654th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 63.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.15%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 20.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,91,11450.6% delivered
Results
Consolidated; ₹ crore.Sudeep Pharma quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹158 Crdown 13.20%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹41 Crdown 16.38%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 25.6%
Revenue by quarter
Peak revenue ₹182 Cr, quarter to Mar 2026; lowest ₹125 Cr, quarter to Jun 2025
Net profit by quarter, a loss in red
| ₹ crore | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 125 | 163 | 172 | 182 | 158 |
| Net profit | 31 | 47 | 48 | 49 | 41 |
| Net margin | 25.0% | 28.8% | 27.7% | 26.6% | 25.6% |
Consolidated. The 5 quarters from Jun 2025, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026
- Revenue
- ₹642 Cr
- Net profit
- ₹174 Cr
- Net margin
- 27.1%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 642 |
| Net profit | 174 |
| Net margin | 27.1% |
Consolidated. Years to March. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Pharmaceutical, food and nutritionPharmaceutical, food and nutrition, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹363 Cr56.5%
- Speciality IngredientsSpeciality Ingredients, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹280 Cr43.5%
Valuation
Today, against the company's own history.Sudeep Pharma PE ratio and valuation
Price to book
At or below today's level on 79% of 209 trading days since Dec 2025.
LowestHighest
Its median10.42Industry median2.48
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 91% of 225 trading days since Nov 2025.
LowestHighest
Its median0.00%Industry median0.55%
Mutual fund holdings
35 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 7 of the 16 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 35 funds holding Sudeep Pharma
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 10
- CutCut. Funds that held fewer shares than at the end of the month before.
- 6
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 18
| Fund | |||
|---|---|---|---|
 Axis Small Cap FundAxis Mutual Fund | 20,02,038 | 0.79% | ₹241.4 Cr |
 SBI Healthcare Opportunities FundSBI Mutual Fund | 13,60,000 | 2.79% | ₹164.0 Cr |
 HDFC Manufacturing fundHDFC Mutual Fund | 8,30,000 | 0.97% | ₹100.1 Cr |
| SBI MNC FundSBI Mutual Fund | 6,87,500 | 1.30% | ₹82.9 Cr |
| SBI COMMA FundSBI Mutual Fund | 6,86,955 | 6.86% | ₹82.8 Cr |
 Edelweiss Recently Listed IPO FundEdelweiss Mutual Fund | 3,83,673 | 3.63% | ₹46.3 Cr |
 Aditya Birla Sun Life Small Cap FundAditya Birla Sun Life Mutual Fund | 3,59,797 | 0.71% | ₹43.4 Cr |
| SBI Retirement Benefit Fund - AggressiveSBI Mutual Fund | 3,27,521 | 1.29% | ₹39.5 Cr |
 TRUSTMF Small Cap FundTrust Mutual Fund | 3,14,018 | 0.98% | ₹37.9 Cr |
 PGIM India Small Cap FundPGIM India Mutual Fund | 2,40,000 | 1.66% | ₹28.9 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Sudeep Pharma insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Others: no market trade · 3 pledge filings of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Sudeep Pharma competitors and peers
Specialty Chemicals, 130 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Sudeep Pharma in market cap.Chemical companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Fine Organic IndustriesFINEORG | 15,660 | 35.74 | 5.88 | +7.3% | +5.7% | 17.7% | 17.6% | 0.22% |
 Privi Speciality ChemicalsPRIVISCL | 13,791 | – | 9.76 | +21.6% | – | – | 21.3% | 0.28% |
 BASF IndiaBASF | 13,535 | 21.05 | 3.42 | +6.7% | +62.4% | 16.9% | 20.2% | 0.80% |
 Anupam Rasayan IndiaANURAS | 12,860 | 73.61 | 3.86 | +51.8% | +41.5% | 5.7% | 6.2% | 0.13% |
 Vinati OrganicsVINATIORGA | 11,354 | 25.32 | 3.59 | +5.1% | +5.4% | 15.1% | 17.3% | 0.78% |
 Jubilant IngreviaJUBLINGREA | 10,072 | 28.73 | 3.04 | +15.4% | +21.7% | 11.0% | 12.0% | 0.79% |
 Elantas Beck IndiaELANTAS | 9,972 | 56.16 | 9.03 | +17.7% | +33.5% | 17.4% | 17.6% | 0.06% |
 Alkyl Amines ChemicalsALKYLAMINE | 8,421 | 37.39 | 5.49 | +5.1% | +20.6% | 15.3% | 17.6% | 0.61% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Sudeep Pharma dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹1.50 a share, year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 23 Jul 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹1.50 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Sudeep Pharma announcements
Oct 2026
21 Oct · Analysts
5 Oct · Management
Sep 2026
23 Sep · Analysts
22 Sep · Analysts
Sudeep Pharma share price by year
Each calendar year to 2025.Sudeep Pharma share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 602.75 | – | 774.15 | 602.75 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 28 Nov 2025.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | 961.20 | 989.90 | 930.70 | 983.00 | 963.90 | 2,36,084 | 38.4% |
| 23 Oct 2026 | 960.00 | 975.90 | 917.40 | 966.20 | 947.61 | 3,80,833 | 51.0% |
| 22 Oct 2026 | 976.50 | 987.00 | 953.70 | 962.00 | 965.74 | 1,95,723 | 50.2% |
| 21 Oct 2026 | 1,010.70 | 1,010.70 | 965.20 | 971.60 | 978.24 | 1,55,840 | 48.5% |
| 19 Oct 2026 | 999.00 | 1,016.80 | 964.70 | 1,003.30 | 987.77 | 1,94,805 | 45.5% |
| 16 Oct 2026 | 1,016.00 | 1,030.00 | 991.00 | 1,000.70 | 1,009.05 | 1,25,394 | 54.1% |
| 15 Oct 2026 | 1,070.00 | 1,073.90 | 1,003.90 | 1,008.10 | 1,025.87 | 1,12,751 | 48.5% |
| 14 Oct 2026 | 1,022.00 | 1,060.20 | 998.20 | 1,055.20 | 1,024.00 | 3,50,474 | 41.1% |
| 13 Oct 2026 | 1,030.00 | 1,031.10 | 981.60 | 1,012.20 | 1,001.99 | 4,07,311 | 62.7% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- SUDEEPPHRM
- BSE code
- 544619
- ISIN
- INE0QPI01025
- Industry
- Chemicals & Petrochemicals
- Website
- www.sudeeppharma.com
- CIN
- U24231GJ1989PLC013141
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1989
- Registered office
- 129/1/A, GIDC Estate, Nandesari, Vadodara 391340, Gujarat
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments